Clinical Trials Insight: 700028550

Trial Profile

Clinical Trials Insight: 700028550

Suspended
Phase of Trial: Phase II/III

Latest Information Update: 15 Jul 2008

At a glance

  • Drugs Adipiplon; Zolpidem
  • Indications Insomnia
  • Focus Therapeutic Use
  • Sponsors Neurogen Corporation
  • Most Recent Events

    • 15 Jul 2008 Status changed to suspended due to a higher than expected rate of adverse events, as reported by Neurogen.
    • 09 Feb 2008 This trial has been modified from a phase III, parallel design to a phase II/III, crossover design.
    • 16 Nov 2007 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top